BeyondSpring Inc. Other Comprehensive Income (Loss), Net of Tax
BeyondSpring Inc. (BYSI) reported Other Comprehensive Income (Loss), Net of Tax of -$541.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- BeyondSpring Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$541.00K.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$426.00K.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$183.00K.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$370.00K, a 328.40% decline year-over-year.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for fiscal 2025 was -$1.25M, a 272.49% decline from fiscal 2024.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $727.00K, a 0.28% increase from fiscal 2023.
- BeyondSpring Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $725.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$541.00K 10-Q · filed 2026-08-14 | -$967.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$426.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | -$1.25M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | -$183.00K 10-Q · filed 2025-11-12 | -$553.00K derived: sum of 2 quarters · filed 2026-08-14 | -$711.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$370.00K 10-Q · filed 2026-08-14 | -$528.00K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$158.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $727.00K 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$901.00K 10-Q · filed 2025-11-12 | -$739.00K derived: sum of 2 quarters · filed 2025-11-12 | -$325.00K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $162.00K 10-Q · filed 2025-11-12 | $576.00K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $414.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $725.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $1.48M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | -$291.00K 20-F · filed 2023-04-18 | |||
| 2020-12-31 | -$530.00K 20-F · filed 2023-04-18 | |||
| 2019-12-31 | $96.00K 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |